Major hepatectomy at interval debulking for Stage IV ovarian carcinoma: A case report

Gynecologic Oncology

Volumn 87, Issue 1, 2002, Pages 138-142

  Chi, Dennis S ^a   Temkin, Sarah M ^b   Abu Rustum, Nadeem R ^a   Sabbatini, Paul ^a   Jarnagin, William R ^a   Blumgart, Leslie H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; TAMOXIFEN; TOPOTECAN;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER BIOPSY; LIVER METASTASIS; LIVER PARENCHYMA; LIVER RESECTION; OVARY CARCINOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0036924887     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6717     Document Type: Article

References (16)

1. Hoskins WJ. Epithelial ovarian carcinoma: Principles of primary surgery. Gynecol Oncol 1994;55:S91-6.
2. Curtin JP, Malik R, Venkatraman ES, Barakat RR, Hoskins WJ. Stage IV ovarian cancer: Impact of surgical debulking. Gynecol Oncol 1997;64:9-12.
3. Chi DS, Liao JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, Hoskins WJ. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001;82:532-7.
4. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Survival impact of cytoreduction in Stage IV epithelial ovarian cancer. Gynecol Oncol 1999;72:278-87.
5. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J, Pecorelli S. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 1995:332;629-34.
6. Chi DS, Fong Y, Venkatraman ES, Barakat RR. Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol 1997;66:45-51.
7. Rose PG, Piver MS, Tsukada Y, Lau TS. Metastatic patterns in histologic variants of ovarian cancer: An autopsy study. Cancer 1989;64:1508-13.
8. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths. Ann Surg 1999;229:322-30.
9. Fong Y, Fortner JG, Sun R, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309-21.
10. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, Blumgart LH. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: Blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998;187:620-5.
11. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE. Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 1994;116:703-11.
12. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-62.
13. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
14. Couinaud C. Bases anatomiques des hepatectomies gauche et droite reglees. J Chir 1954;70:933-66.
15. DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000;4:178-84.
16. Bilchik AJ, Wood TF, Allegra DP. Radiofrequency ablation of unresectable hepatic malignancies: Lessons learned. [see comments]. Oncologist 2001;6:24-33.